BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24424386)

  • 21. The role of clinicopathologic and molecular prognostic factors in the post-mastectomy radiotherapy (PMRT): a retrospective analysis of 912 patients.
    Ursino S; Fiorica F; Mazzotti V; Delishaj D; Cristaudo A; Spagnesi S; Laliscia C; Pasqualetti F; Fontana A; Ghilli M; Morganti R; Falcone A; Roncella M; Paiar F
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2157-2166. PubMed ID: 28537668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmastectomy irradiation in breast in breast cancer patients with T1-2 and 1-3 positive axillary lymph nodes: is there a role for radiation therapy?
    Cosar R; Uzal C; Tokatli F; Denizli B; Saynak M; Turan N; Uzunoglu S; Ozen A; Sezer A; Ibis K; Uregen B; Yurut-Caloglu V; Kocak Z
    Radiat Oncol; 2011 Mar; 6():28. PubMed ID: 21450076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of molecular subtype on locoregional recurrence in mastectomy patients with T1-T2 breast cancer and 1-3 positive lymph nodes.
    Moo TA; McMillan R; Lee M; Stempel M; Ho A; Patil S; El-Tamer M
    Ann Surg Oncol; 2014 May; 21(5):1569-74. PubMed ID: 24488216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?
    Jwa E; Shin KH; Lim HW; Jung SY; Lee S; Kang HS; Lee E; Park YH
    PLoS One; 2015; 10(12):e0145463. PubMed ID: 26691445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment.
    McBride A; Allen P; Woodward W; Kim M; Kuerer HM; Drinka EK; Sahin A; Strom EA; Buzdar A; Valero V; Hortobagyi GN; Hunt KK; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):392-8. PubMed ID: 24721590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy.
    Macdonald SM; Abi-Raad RF; Alm El-Din MA; Niemierko A; Kobayashi W; McGrath JJ; Goldberg SI; Powell S; Smith B; Taghian AG
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1297-303. PubMed ID: 19327896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of postmastectomy radiation therapy on high-risk patients with T1-2N0 breast cancer.
    Luo C; Zhong X; Fan Y; Wang C; Wang Y; Luo T
    Breast; 2021 Dec; 60():1-5. PubMed ID: 34455226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival.
    Woodward WA; Truong PT; Yu TK; Tereffe W; Oh J; Perkins G; Strom E; Meric-Bernstam F; Gonzalez-Angulo AM; Speers C; Ragaz J; Buchholz TA
    Breast Cancer Res Treat; 2010 Sep; 123(2):597-605. PubMed ID: 20306128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy.
    Stauder MC; Caudle AS; Allen PK; Shaitelman SF; Smith BD; Hoffman KE; Buchholz TA; Chavez-Macgregor M; Hunt KK; Meric-Bernstam F; Woodward WA
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):637-44. PubMed ID: 27681760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiotherapy after skin-sparing mastectomy with immediate breast reconstruction in intermediate-risk breast cancer : Indication and technical considerations.
    Hehr T; Baumann R; Budach W; Duma MN; Dunst J; Feyer P; Fietkau R; Haase W; Harms W; Krug D; Piroth MD; Sedlmayer F; Souchon R; Wenz F; Sauer R;
    Strahlenther Onkol; 2019 Nov; 195(11):949-963. PubMed ID: 31451835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a prognostic scoring system for postmastectomy locoregional recurrence in breast cancer.
    Van der Vorst A; Kindts I; Laenen A; Neven P; Janssen H; Weltens C
    Breast; 2022 Aug; 64():29-34. PubMed ID: 35468477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy.
    Cheng JC; Chen CM; Liu MC; Tsou MH; Yang PS; Jian JJ; Cheng SH; Tsai SY; Leu SY; Huang AT
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):980-8. PubMed ID: 11958892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of isolated tumor cells on loco-regional recurrence in breast cancer patients treated with breast-conserving treatment or mastectomy without post-mastectomy radiation therapy.
    Keruakous AR; Sadek BT; Shenouda MN; Niemierko A; Abi Raad RF; Specht M; Smith BL; Taghian AG
    Breast Cancer Res Treat; 2014 Jul; 146(2):365-70. PubMed ID: 24952906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
    Mamtani A; Patil S; Stempel MM; Morrow M
    Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is avoiding post-mastectomy radiotherapy justified for patients with four or more involved axillary nodes and endocrine-responsive tumours? Lessons from a series in a single institution.
    Gentilini O; Botteri E; Rotmensz N; Intra M; Gatti G; Silva L; Peradze N; Sahium RC; Gil LB; Luini A; Veronesi P; Galimberti V; Gandini S; Goldhirsh A; Veronesi U
    Ann Oncol; 2007 Aug; 18(8):1342-7. PubMed ID: 17693648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
    He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
    PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of postmastectomy radiotherapy on pT
    Guo XY; Sun GY; Wang HM; Liu M; Zhang YJ; Zhang N; Tang Y; Zhao XR; Jing H; Fang H; Wen G; Guo QS; Wu HF; Wang XH; Ma CY; Li YX; Cheng J; Shi M; Wang SL
    Breast; 2022 Feb; 61():108-117. PubMed ID: 34942430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
    Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
    [No Abstract]   [Full Text] [Related]  

  • 39. Post-mastectomy radiation therapy in breast cancer patients with 1-3 positive lymph nodes: No one size fits all.
    Kayali M; Abi Jaoude J; Tfayli A; El Saghir N; Poortmans P; Zeidan YH
    Crit Rev Oncol Hematol; 2020 Mar; 147():102880. PubMed ID: 32045847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-mastectomy Radiation Therapy in Breast Cancer Patients with Nodal Micrometastases.
    Wu SP; Tam M; Shaikh F; Lee A; Chun J; Schnabel F; Guth A; Adams S; Schreiber D; Oh C; Gerber NK
    Ann Surg Oncol; 2018 Sep; 25(9):2620-2631. PubMed ID: 29987606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.